Laura C. Hart

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

K. Myers, S. Davies, P. Mehta, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical evaluation and mitochondrial DNA sequence analysis in two Chinese families with aminoglycoside-induced and non-syndromic hearing loss.

Ronghua Li, Qiuju Wang, Yaping Qian, 2005, Biochemical and biophysical research communications.